NASDAQ:FDMT | Cash Flow Statement | 4D Molecular Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$72.94M
2026-03-31-$68.76M-$68.13M$68.89M$11.48M
2025-12-31$19.4M$28.55M-$70,000.00-$128.85M$111.98M
2025-09-30-$56.88M
2025-06-30-$54.66M
2025-03-31-$47.97M-$47.76M$631,000.00$31.95M$0.00
2024-12-31-$49.67M-$45.86M$949,000.00$7.06M$601,000.00
2024-09-30-$43.84M
2024-06-30-$34.95M
2024-03-31-$32.4M-$29.09M$710,000.00-$263.26M$318.83M
2023-12-31-$32.28M-$24.65M$549,000.00-$6.68M$4.76M
2023-09-30-$10.26M
2023-06-30-$29.62M
2023-03-31-$28.68M-$27.91M$1.01M$43.13M$10.99M
2022-12-31-$27.38M-$22.21M$1.09M-$35.78M$2.05M
2022-09-30-$25.69M
2022-06-30-$28.09M
2022-03-31-$26.34M-$23.55M$6.41M-$54.11M$629,000.00
2021-12-31-$25.08M-$21.84M$5.1M-$32.29M$116.14M
2021-09-30-$22.24M
2021-06-30-$7.59M
2021-03-31-$16.41M-$15.37M$642,000.00-$642,000.00-$847,000.00
2020-12-31-$20.55M-$17.5M$508,000.00-$508,000.00$205.98M
2020-09-30-$7.83M
2020-06-30-$15.15M
2020-03-31-$13.16M-$13.87M$721,000.00-$721,000.00-$389,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$140.11M-$109.08M$536,000.00-$92.97M$112.96M
2024-12-31-$160.87M-$134.59M$3.79M-$302.44M$337.25M
2023-12-31-$100.84M-$75.79M$2.77M$115.72M$156.83M
2022-12-31-$107.49M-$86.69M$11.54M-$17.05M$3.09M
2021-12-31-$71.32M-$69.13M$9.11M-$172.68M$118.09M
2020-12-31-$56.69M-$50.91M$1M-$1M$278.98M
2019-12-31-$49.31M-$36.71M$3.2M-$3.2M-$2.2M